top of page
Icon_PrIMAVeRa_transparent_high_res_edit

Publications

This is a list of publications related to the work of the PrIMAVeRa Consortium published in scientific journals. Please contact the Project Leader for more information, or if a relevant publication is missing: irina.meln@euvaccine.eu

The neglected model validation of antimicrobial resistance transmission models - a systematic review.

2025

Brinch ML, Palladino A, Geurtsen J, Van Effelterre T, Argante L, McConnell MJ, Christiansen L, Pihl MA, Lund NK, Hald T.

Antimicrob Resist Infect Control. 2025 May 28;14(1):59.

Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients - a longitudinal study over 20 years.

2025

Hassoun-Kheir N, Buetti N, Olivier V, Perez M, Frossard J, Renzi G, Schrenzel J, Saudan P, Harbarth S.

J Hosp Infect. 2023 May;135:55-58.

How to: share and reuse data-challenges and solutions from predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance project.

2025

Guedes M, de la Serna Bazan A, Rubio-Martín E, Pulido LB, Palomo V, Piljić A, Leclerc QJ, Aris E, Vella V, Dambrauskienė A, Robotham JV, Pérez A, Hassoun-Kheir N, de Kraker MEA, Arieti F, Davis RJ, Tacconelli E, Salamanca-Rivera E, Rodríguez-Baño J.

Clin Microbiol Infect. 2025 May;31(5):753-760.

The AMR Accelerator: from individual organizations to efficient antibiotic development partnerships.

2025

Fernow J, Olliver M, Couet W, Lagrange S, Lamers MH, Olesen OF, Orrling K, Pieren M, Sloan DJ, Vaquero JJ, Miles TJ, Karlén A.

Nat Rev Drug Discov. 2025 Jan;24(1):1-2.

Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodies.

2024

Hassoun-Kheir N, Guedes M, Arieti F, Pezzani MD, Gladstone BP, Robotham JV, Pouwels KB, Kingston R, Carmeli Y, Cassini A, Cecchini M, Drobniewski F, Frost I, Geurtsen J, Kronenberg A, Htay MNN, Paul M, Rocha-Pereira N, Rodríguez-Baño J, Scudeller L, Stewardson AJ, Tacconelli E, Harbarth S, Vella V, de Kraker ME.

Euro Surveill. 2024 Nov;29(47):2400212.

A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.

2024

Hassoun-Kheir N, Guedes M, Ngo Nsoga MT, Argante L, Arieti F, Gladstone BP, Kingston R, Naylor NR, Pezzani MD, Pouwels KB, Robotham JV, Rodríguez-Baño J, Tacconelli E, Vella V, Harbarth S, de Kraker MEA; PrIMAVeRa Workpackage 1.

Clin Microbiol Infect. 2024 Mar;30 Suppl 1:S14-S25.

Using contact network dynamics to implement efficient interventions against pathogen spread in hospital settings: A modelling study.

2024

Leclerc QJ, Duval A, Guillemot D, Opatowski L, Temime L.

PLoS Med. 2024 Jul 30;21(7):e1004433.

Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis.

2024

Kingston R, Vella V, Pouwels KB, Schmidt JE, Abdelatif El-Abasiri RA, Reyna-Villasmil E, Hassoun-Kheir N, Harbarth S, Rodríguez-Baño J, Tacconelli E, Arieti F, Gladstone BP, de Kraker MEA, Naylor NR, Robotham JV; PrIMAVeRa Work Package 1.

Clin Microbiol Infect. 2024 Mar;30 Suppl 1:S26-S36.

Synthesizing pathogen- and infection-specific estimates of the burden of antimicrobial resistance in Europe for health-technology assessment: gaps, heterogeneity, and bias.

2024

Robotham JV, Tacconelli E, Vella V, de Kraker MEA.

Clin Microbiol Infect. 2024 Mar;30 Suppl 1:S1-S3.

Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review.

2024

Pezzani MD, Arieti F, Rajendran NB, Barana B, Cappelli E, De Rui ME, Galia L, Hassoun-Kheir N, Argante L, Schmidt J, Rodriguez-Bano J, Harbarth S, de Kraker M, Gladstone BP, Tacconelli E.

Clin Microbiol Infect. 2024 Mar;30 Suppl 1:S4-S13.

Estimating antimicrobial resistance burden in Europe-what are the next steps?

2022

Hassoun-Kheir N, Harbarth S.

Lancet Public Health. 2022 Nov;7(11):e886-e887.

Global burden of antimicrobial resistance: essential pieces of a global puzzle.

2022

de Kraker MEA, Harbarth S.

Lancet. 2022 Jun 25;399(10344):2347.

efpia.png

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034420. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

EU_flag.png
imi_logo.png

This communication reflects the authors' view(s) and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

Join European Vaccine Initiative mailing list for updates on projects, training and funding opportunities

Thanks for submitting! You can unsubscribe at anytime.

  • LinkedIn
  • Twitter
  • YouTube

© 2024 European Vaccine Initiative. Designed by European Vaccine Initiative

EVI_Logo_White_Website_2020.png
bottom of page